Vendeur : HPB-Red, Dallas, TX, Etats-Unis
EUR 11,41
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Vendeur : ThriftBooks-Atlanta, AUSTELL, GA, Etats-Unis
EUR 14,95
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Dallas, Dallas, TX, Etats-Unis
EUR 14,95
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Atlanta, AUSTELL, GA, Etats-Unis
EUR 14,95
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
EUR 16,17
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
EUR 16,98
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : New.
Vendeur : HPB-Movies, Dallas, TX, Etats-Unis
EUR 35,49
Quantité disponible : 1 disponible(s)
Ajouter au panierhardcover. Etat : Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Langue: anglais
Edité par Berlin/ Heidelberg, Springer Berlin., 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : Universitätsbuchhandlung Herta Hold GmbH, Berlin, Allemagne
EUR 18
Quantité disponible : 1 disponible(s)
Ajouter au panier2010. 16 x 24 cm. XIV, 231 S. XIV, 231 p. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Recent Results in Cancer Research). Sprache: Englisch.
Vendeur : Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Royaume-Uni
EUR 28,25
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New.
EUR 16,80
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : New.
EUR 19,62
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Royaume-Uni
EUR 42,02
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : As New.
Vendeur : Antiquariat Bookfarm, Löbnitz, Allemagne
EUR 8,25
Quantité disponible : 1 disponible(s)
Ajouter au panier808 Seiten Ehemaliges Bibliotheksexemplar mit Stempel und Rückensignatur. Leichte bis Moderate Lager und Gebrauchsspuren. Guter Zustand. 9783836216227 Sprache: Deutsch Gewicht in Gramm: 1461.
Vendeur : Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Royaume-Uni
EUR 75,39
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : As New.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 29,90
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 126,38
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 143,84
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 165,27
Quantité disponible : 2 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. 2010 edition. 248 pages. 9.20x6.10x0.56 inches. In Stock.
Vendeur : preigu, Osnabrück, Allemagne
EUR 104,15
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Angiogenesis Inhibition | Rüdiger Liersch (u. a.) | Taschenbuch | xiv | Englisch | 2012 | Springer | EAN 9783642261435 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Langue: anglais
Edité par Springer Berlin Heidelberg, 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 117,69
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 198,86
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 160,49
Quantité disponible : 1 disponible(s)
Ajouter au panierBuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 235,65
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 248.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 233,72
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Brand New. 1st edition. 231 pages. 9.00x6.00x0.50 inches. In Stock.
Langue: allemand
ISBN 10 : 3836228718 ISBN 13 : 9783836228718
Vendeur : medimops, Berlin, Allemagne
EUR 36,84
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : good. Befriedigend/Good: Durchschnittlich erhaltenes Buch bzw. Schutzumschlag mit Gebrauchsspuren, aber vollständigen Seiten. / Describes the average WORN book or dust jacket that has all the pages present.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 7,69
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Seiten: 866 | Produktart: Bücher | Keine Beschreibung verfügbar.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 7,69
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Seiten: 952 | Produktart: Bücher | Keine Beschreibung verfügbar.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 94,25
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 126,26
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Langue: anglais
Edité par Springer Berlin Heidelberg Mai 2012, 2012
ISBN 10 : 3642261434 ISBN 13 : 9783642261435
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 117,69
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. 248 pp. Englisch.